Smith & Nephew
SNN
#1658
Rank
$12.99 B
Marketcap
$31.05
Share price
-0.32%
Change (1 day)
-6.90%
Change (1 year)
Categories
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company.

P/E ratio for Smith & Nephew (SNN)

P/E ratio as of November 2026 (TTM): 27.7

According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.656. At the end of 2013 the company had a P/E ratio of 23.2.

P/E ratio history for Smith & Nephew from 2001 to 2014

PE ratio at the end of each year

Year P/E ratio Change
201323.269.1%
201213.7-6.9%
201114.8-2.9%
201015.2-20.87%
200919.226.58%
200815.2-54.84%
200733.6154.1%
200613.21347.77%
20050.9131-99.14%
200410616.14%
200391.044.53%
200263.0-75.49%
2001257

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
42.2 52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
18.6-32.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
60.4 118.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
33.7 21.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Orthofix Medical
OFIX
-4.68-116.93%๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
28.4 2.61%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.